Literature DB >> 15449710

Cellular prion protein acquires resistance to proteolytic degradation following copper ion binding.

Thorsten Kuczius1, Anne Buschmann, Wenlan Zhang, Helge Karch, Karsten Becker, Georg Peters, Martin H Groschup.   

Abstract

The conversion of cellular prion protein (PrP(C)) into its pathological isoform (PrP(Sc)) conveys an increase in hydrophobicity and induces a partial resistance to proteinase K (PK). Interestingly, co-incubation with high copper ion concentrations also modifies the solubility of PrP(c) and induces a partial PK resistance which was reminiscent of PrP(Sc). However, concerns were raised whether this effect was not due to a copper-induced inhibition of the PK itself. We have therefore analyzed the kinetics of the formation of PK-resistant PrP(C) and excluded possible interference effects by removing unbound copper ions prior to the addition of PK by methanol precipitation or immobilization of PrP(C) followed by washing steps. We found that preincubation of PrPc with copper ions at concentrations as low as 50 microM indeed rendered these proteins completely PK resistant, while control substrates were proteolyzed. No other divalent cations induced a similar effect. However, in addition to this specific stabilizing effect on PrP(C), higher copper ion concentrations in solution (>200 microM) directly blocked the enzymatic activity of PK, possibly by replacing the Ca2+ ions in the active center of the enzyme. Therefore, as a result of this inhibition the proteolytic degradation of PrP(C) as well as PrP(Sc) molecules was suppressed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15449710     DOI: 10.1515/BC.2004.090

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  11 in total

Review 1.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

2.  Separation of native prion protein (PrP) glycoforms by copper-binding using immobilized metal affinity chromatography (IMAC).

Authors:  Henrik Müller; Alexander Strom; Gerhard Hunsmann; Andreas W Stuke
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

Review 3.  The intriguing prion disorders.

Authors:  K Abid; C Soto
Journal:  Cell Mol Life Sci       Date:  2006-10       Impact factor: 9.261

4.  Ligand binding promotes prion protein aggregation--role of the octapeptide repeats.

Authors:  Shuiliang Yu; Shaoman Yin; Nancy Pham; Poki Wong; Shin-Chung Kang; Robert B Petersen; Chaoyang Li; Man-Sun Sy
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

Review 5.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

6.  Molecular dynamics simulations of two tandem octarepeats from the mammalian prion protein: fully Cu2+-bound and metal-free forms.

Authors:  M Jake Pushie; Hans J Vogel
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

7.  Disruption of copper homeostasis due to a mutation of Atp7a delays the onset of prion disease.

Authors:  Owen M Siggs; Justin T Cruite; Xin Du; Sophie Rutschmann; Eliezer Masliah; Bruce Beutler; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

8.  Prion sequence polymorphisms and chronic wasting disease resistance in Illinois white-tailed deer (Odocoileus virginianus).

Authors:  Amy C Kelly; Nohra E Mateus-Pinilla; Jay Diffendorfer; Emily Jewell; Marilyn O Ruiz; John Killefer; Paul Shelton; Tom Beissel; Jan Novakofski
Journal:  Prion       Date:  2008-01-20       Impact factor: 3.931

Review 9.  Prion protein and metal interaction: physiological and pathological implications.

Authors:  Neena Singh; Dola Das; Ajay Singh; Maradumane L Mohan
Journal:  Curr Issues Mol Biol       Date:  2009-09-18       Impact factor: 2.081

Review 10.  Prion protein misfolding.

Authors:  L Kupfer; W Hinrichs; M H Groschup
Journal:  Curr Mol Med       Date:  2009-09       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.